Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Liposarcoma × Neoadjuvant Therapy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 80 Colorectal Neoplasms 42 Rectal Neoplasms 41 Carcinoma, Non-Small-Cell Lung 28 Esophageal Neoplasms 22 Lung Neoplasms 20 Esophageal Squamous Cell Carcinoma 20 Stomach Neoplasms 17 Pancreatic Neoplasms 17 Neoplasms 14 Colonic Neoplasms 13 Carcinoma, Hepatocellular 13 Neoplasm Metastasis 12 Squamous Cell Carcinoma of Head and Neck 11 Ovarian Neoplasms 11 Adenocarcinoma Of Esophagus 11 Urinary Bladder Neoplasms 10 Sarcoma 10 Prostatic Neoplasms 10 Head and Neck Neoplasms 10 Uterine Cervical Neoplasms 8 Fallopian Tube Neoplasms 8 Osteosarcoma 7 Inflammatory Breast Neoplasms 7 Central Nervous System Neoplasms 7 Multiple Myeloma 6 Liver Neoplasms 6 Carcinoma, Intraductal, Noninfiltrating 6 Recurrence 5 Kidney Neoplasms 5

Interventions

Doxorubicin 20 Trabectedin 10 Radiotherapy 10 Ifosfamide 10 pazopanib 5 Gemcitabine 5 ribociclib 4 Specimen Handling 4 Docetaxel 4 Biopsy 4 selinexor 3 pembrolizumab 3 palbociclib 3 eribulin 3 X-Rays 3 Filgrastim 3 Cyclophosphamide 3 temsirolimus 2 pegfilgrastim 2 liposomal doxorubicin 2 cixutumumab 2 brostallicin 2 brigimadlin 2 belinostat 2 avelumab 2 abemaciclib 2 Vincristine 2 Temozolomide 2 Surgical Procedures, Operative 2 Sunitinib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04031677 2026-03-18

STRASS2

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Recruiting

Leiomyosarcoma, Liposarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡